These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34649705)

  • 61. Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.
    Amin A; Keshishian A; Dina O; Dhamane A; Nadkarni A; Carda E; Russ C; Rosenblatt L; Mardekian J; Yuce H; Baker CL
    J Thromb Thrombolysis; 2019 Aug; 48(2):240-249. PubMed ID: 30924051
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to emergent reversal.
    Gehrie E; Tormey C
    Arch Pathol Lab Med; 2015 May; 139(5):687-92. PubMed ID: 25927153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An update on hip fracture risk associated with anticoagulant therapy: warfarin versus direct oral anticoagulants.
    Sugiyama T
    Expert Opin Drug Saf; 2020 Oct; 19(10):1219-1220. PubMed ID: 32795203
    [No Abstract]   [Full Text] [Related]  

  • 64. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
    Fenger-Eriksen C; Münster AM; Grove EL
    Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
    Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
    Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Impairment in Kidney Function in the Oral Anticoagulation Era. A Pathophysiological Insight.
    Scicchitano P; Tucci M; Bellino MC; Cortese F; Cecere A; De Palo M; Massari F; Caldarola P; Silvestris F; Ciccone MM
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):505-519. PubMed ID: 32535717
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
    Yanagisawa D; Abe K; Amano H; Komatsuda S; Honda T; Manabe D; Yamamoto H; Kozuma K; Kodashima S; Asaoka Y; Yamamoto T; Tanaka A
    PLoS One; 2021; 16(11):e0260585. PubMed ID: 34843582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
    Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Direct-acting oral anticoagulants: a bridge to nowhere.
    Sheppard MA; Levy R; Patanwala AE
    Med J Aust; 2019 May; 210(9):429-429.e1. PubMed ID: 31025707
    [No Abstract]   [Full Text] [Related]  

  • 70. A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures.
    Marsh K; Ahuja T; Raco V; Green D; Sista AK; Papadopoulos J
    J Thromb Thrombolysis; 2018 Nov; 46(4):451-460. PubMed ID: 30225669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
    Ruff CT; Giugliano RP; Braunwald E; Morrow DA; Murphy SA; Kuder JF; Deenadayalu N; Jarolim P; Betcher J; Shi M; Brown K; Patel I; Mercuri M; Antman EM
    Lancet; 2015 Jun; 385(9984):2288-95. PubMed ID: 25769361
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk of major bleeding in elderly patients with atrial fibrillation on direct oral anticoagulants: real world experience.
    Šinigoj P; Vene N; Košmelj K; Mavri A
    Int J Clin Pharm; 2020 Apr; 42(2):445-452. PubMed ID: 32170590
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
    Bohula EA; Giugliano RP; Ruff CT; Kuder JF; Murphy SA; Antman EM; Braunwald E
    Circulation; 2016 Jul; 134(1):24-36. PubMed ID: 27358434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding.
    Hospodar AR; Smith KJ; Zhang Y; Hernandez I
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):317-325. PubMed ID: 29740750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and efficacy of new oral anticoagulants compared to those of warfarin in AF patients with cancer: a meta-analysis of randomized clinical trials and observational studies.
    Chen Y; Mao M; Chang J; Yan J; Yang T; Liu Y; Luo M; Hu Y; Yang Q; Zhou L; Ma K
    Eur J Clin Pharmacol; 2021 Jun; 77(6):849-857. PubMed ID: 33791828
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
    Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Peripheral Artery Disease: a Systematic Review and Meta-Analysis.
    Liao XZ; Fu YH; Ma JY; Zhu WG; Yuan P
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):391-399. PubMed ID: 32206988
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis.
    Elshafei MN; Mohamed MFH; El-Bardissy A; Ahmed MB; Abdallah I; Elewa H; Danjuma M
    J Thromb Thrombolysis; 2021 Feb; 51(2):388-396. PubMed ID: 32556939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Management of anticoagulation with rivaroxaban in trauma and acute care surgery: Complications and reversal strategies as compared to warfarin therapy.
    Myers SP; Dadashzadeh ER; Cheung J; Alarcon L; Kutcher M; Brown JB; Neal MD
    J Trauma Acute Care Surg; 2017 Mar; 82(3):542-549. PubMed ID: 28045742
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
    Chen HY; Ou SH; Huang CW; Lee PT; Chou KJ; Lin PC; Su YC
    Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.